BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Prologue Research International People News: Art Ziegler Joins Prologue as the New VP, Business Development


1/7/2010 10:51:48 AM

COLUMBUS, OH--(Marketwire - January 07, 2010) -

Prologue is pleased to announce the arrival of our new Vice President of Business Development. Art Ziegler brings with him 25 years of clinical research and business development experience. As Vice President of Business Development, his primary roles will include securing levels of sustainable, profitable revenue necessary to meet the company's financial objectives through effective sales and marketing strategies, developing and implementing marketing and sales initiatives to create awareness and demand for Prologue services within the oncology clinical research community and identifying, and meeting key decision makers of potential clients.

Prior to joining Prologue, Mr. Ziegler held various positions at Pharmaceutical (Smithkline & French Laboratories), Biotech (Ortho Biotech - JNJ), SMO (Florida Pharmaceutical Research) and CRO (Premier Research) companies. Prologue wholeheartedly welcomes him to the team and looks forward to his guidance as we continue to grow as "The Oncology CRO."

Prologue Research is a leading global oncology contract research organization (CRO) founded in 1998. The Company offers a full range of clinical research services for Phase I-IV international or US-based clinical trials in oncology. Prologue provides its clients with world-class experience, a deeply qualified staff, and state-of-the-art systems uniquely designed for complicated oncology trials. We offer the expertise, service and talent that enables our sponsors to make an impact in the lives of people with cancer.

For more information about this appointment or to learn more about Prologue's full range of oncology clinical trial services, please visit our website at www.procro.com or email info@procro.com.


Contact:
Dr. Andrew Zupnick
Phone: 614.324.1500
Email: Email Contact

Digg this    Bookmark with del.icio.us    Add to Newsvine

Technorati:



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES